Trial intelligence / Profile preview

Cryopreserved vs fresh allogeneic peripheral blood stem cell transplantation at Siriraj Hospital

TCTR20240612001Unknown

Sponsor
Siriraj Hospital
Start
Mar 2024
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Randomised, open-label trial of allogeneic peripheral blood progenitor cells in hematopoietic malignancies and bone marrow failure (2 arms), sponsored by Siriraj Hospital. Primary endpoint: Transplant effectiveness. Status: unknown.

02

Drugs

allogeneic peripheral blood progenitor cells
03

Conditions

hematopoietic malignanciesbone marrow failure

Beyond the preview

Go deeper on TCTR20240612001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240612001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call